Program and Sessions Summary

Tuesday, November 2nd,  1999

Venue:  The Capitol Washington DC, Hall HC-5 
Time:  6pm - 8pm - Registration
- Reception
Wednesday, November 3rd, 1999
Venue:  Holiday Inn, Silver Spring, MD
Time: 7am - 9am - Registration
- Opening Ceremony
- Plenary Session 1
- Festival of Living Culture
- Exhibit Poster Session
- Plenary Session 2
- Plenary Session 3
- BDCP Meeting
Thursday, November 4th, 1999
Venue:  Holiday Inn, Silver Spring, MD
Time: 8am - 9am - Plenary Session 4
- Exhibit Poster Session

- Plenary Session 5
 (Colloquium on Garcinia Kola)

 - Plenary Session 6
 - Dinner
Friday, November 5th, 1999
Venue:  Holiday Inn, Silver Spring, MD
Time: 7am - 9am - Plenary Session 7
- Exhibit Poster Session
- Plenary Session 8
- Plenary Session 9


Medicinal Plants in Emerging Infectious Diseases and AIDS

Over 300 generic infectious diseases are distributed haphazardly in time and space. More than one thousand pathogenic bacteria, viruses, parasites and fungi have been described. This session will focus on major infectious, parasitic, nutritional and chronic diseases of both developing and developed countries including their public health impacts.

SESSION 1 SPEAKERS              

Gordon Cragg 
National Cancer Institute, National Institutes of Health, USA

- Drugs from Nature: Past Achievements, Future Prospects         

Alice Clark 
University of Mississippi, USA

-Targeting Virulence Factors for the Discovery of Plant-Derived Anti-Infectives   


Otto Sticher
Swiss Federal Institute of Technology, Switzerland

Bioactive Metabolites From Plants Used In The Traditional Medicine of Papua New Guinea and Mexico                                              

Simon Croft
London School of Hygiene and Tropical Medicine, UK

Plant Products and Antiprotozoal Chemotherapy
Jackie Wootton
Alternative Medicine Foundation, USA
Development of HerbmedTm, and Interactive, Evidence-Based Herbal Database
S. Mbua Ngale Efange
University of Minnesota, USA

Natural Products: A Continuing Source of Inspiration for the Medicinal Chemist




Ethical and policy issues of bioprospecting/Business Opportunities and the Role of Industry in Ethnobotany

A significant part of the ethnomedical approach involves the use of knowledge collected from indigenous native populations and therefore serious thought has to be given to resolving inherent ethical, social values and policy issues. This session will review how and to what extent can cultural, ethical and social structures be incorporated into technical and scientific developments. Discussion s and debates on intellectual property systems, patent requirements and international agreements will be done.


Session 2 Speakers

Katy Moran
Healing Forest Conservancy, USA

Mechanisms for Benefit Sharing
Thomas Mays
Morrison and Forester, USA

Effective Benefit Sharing Mechanisms to Promote Ethnomedicine and Drug Discovery
Michael Gollin
Venable, Baetjer, Howard & Civiletti, LLP, USA

Intellectual Property Rights and Traditional Medicine
Joerg Grunewald
PhytoPharm Consulting GmbH, Germany

The World Market of Herbal Medicines, From Extracts to New Ingredients
Peggy Brevoort
Folexco/East Earth Herb, USA

The Current Market For Medicinal Herbs in the Americas
Herbert Schwabl
Padma Inc., Switzerland

Marketing Tibetan Herbals Based on Ancient Multi-Component Recipes




Networking with Shaman and Community reciprocity

The advent of ethnomedicine comes with benefit sharing arising from plant-based drug discovery and commercialization. Strategies and experience in networking and returning short and long-term benefits to healers, communities and culture groups will be discussed.


Session 3 Speakers

Steven King
Shaman Botanicals Inc., USA

Applied Research, Sustainable Management and Reaching Multiple Levels of Stakeholders: Contributions to the Commercialization of Botanical Medicines

Mike Balick
New York Botanical Garden, USA

(to be announced)

James Miller
Missouri Botanical Garden, USA

Beyond the Convention on Biological Diversity: International Bioprospecting Agreements as a Tool to Achieve Equitable Benefit Sharing

Dave Stephenson
Brauchli-Synder, LLC, USA

Indigenous Peoples’ Right and Drug Development Using Traditional Medicine



Ethnobotanical Approach to Drug Discovery: Strengths and Limitations

Advances in Biotechnology and molecular science have made it increasingly feasible to transform traditional medicine from an almost invisible health care system to a modern venture. Nearly always, the active compounds isolated from plants contain new moieties, which serve as templates for the synthesis of a wide range of therapeutic agents often with novel mechanisms of action. This session will discuss the strengths, limitations and future of this drug discovery approach.


Session 4 Speakers

Alan Harvey
Strathclyde Institute for Drug Research, UK
What To Do If Traditional Leads Fail? Other Approaches To Drug Discovery From Natural Products

Paul Alan Cox
National Tropical Botanical Garden, USA
(to be announced)

Brian Schuster
Walter Reed Army Institute of Research, USA
(to be announced)

B.N. Dhawan
Central Drug Research Institute, India
Multiple Strategies For Development Of New Drugs From Natural Products

Joshua Rosenthal
Fogarty International, National Institutes of Health, USA
Traditional Knowledge And Modern Drug Discovery Systems: Opportunities and Challenges

Larry Walker
University of Mississippi, USA
New Therapies From Plant Sources: Drug Discovery Approaches At The National Center For Natural Products Research

Ezio Bombardelli
Indena, Italy

(to be announced)

P.Y. Guru
Central Drug Research Institute, India

Perspective On Utilization Of Knowledge From Indian Traditional Remedies For Identifying And Developing Potential Therapeutic Agents For Some Parasitic Diseases – Problem And Prospects

Johnson Ayafor
University of Dschang, Cameroon

Chemical Diversity In The Genus Aframomum K. Schum.: A Major Source Of Ethnomedicine In West And Central Africa

Jerry Cott
National Center for Complimentary and Alternative Medicine, USA

Research Supported By The NIH On Psychoactive Botanicals

Jody Noe
Brattleboro Naturopathic Clinic, USA

Ethnomedicine Of The Cherokee: Historical And Current Applications



Colloquium on Garcinia Kola

Garcinia kola Heckel (Family Guttifereae) known in commerce as "bitter cola" is a highly valued ingredient in African traditional medicine. The plant is cultivated through out West Africa for its edible fruit and seeds which has been employed in folk medicine as rejuvenating agent and general antidote. Bitter cola seeds have been shown to contain a complex mixture of biflavonoids, prenylated benzophenones and xanthones. 

Many pharmacological effects have been demonstrated for Garcinia biflavonoids, among them are antiviral, anti-inflammatory, antidiabetic, bronchodilator, antihepatotoxic properties, other studies show that antimicrobial activity was due to polyisoprenylated benzophenone. Some proprietary dietary supplements containing Garcinia kola extractives already exist in US and African markets.

This colloquium is centered on G. Kola, its constituents and application in medicine. The ethnobotany, clinical uses, chemistry, pharmacology and commercialization of Garcinia extracts and compounds as well as analytical methods for quantification of marker compounds in these preparations will be discussed. Additionally, all proprietary products are discussed and evaluated on the content of human safety


Session 5 Speakers

Maurice Iwu
Bioresources Development and Conservation Programme, USA

Garcinia kola: A New Adaptogenic Agent

Lisa Meserole
Botanical Medicine Academy, USA

Garcinia kola in Clinical Therapeutics – Present And Potential Indications
As A Tonic And Therapeutic Medicine

Angela Kanu
North Carolina, USA

Pharmacological Profiles of Garcinia kola

Govind Kapadia
Howard University, Washington DC, USA

The Chemical Constituents Of Garcinia species

Chris Okunji
Walter Reed Army Institute of Research, USA

Challenges And Issues Involved In The Standardization of Garcinia kola

Angela Duncan
Axxon Biopharm Inc., USA

Garcinia kola: The Market, Seeds Of Opportunity



Dietary Supplements – New ingredients From Nature

Unravel the food-supplement connection. What’s "In Store" for tomorrow’s shoppers?  A panel of experts will share the latest food industry market research and predict what customers will be buying in the new millennium


Session 6 Speakers 

Christine Swanson
Office of Dietary Supplements, National Institutes of Health, USA

The Office Of Dietary Supplements (ODS) At The NIH:
An Overview Of Activities Related To Botanicals

A.Douglas Kinghorn
University of Illinois at Chicago, USA

Stevia rebaudiana and Stevioside as Sucrose Substituents: Current Status

Mike Tempesta
NatProd Consulting Services, USA

Overview of New Technologies in the US Herbal Market



Regulatory requirements and standardization of medicinal and aromatic plants

Development of phytomedicines could provide a more affordable, and in some cases more effective, form of local health care. This session will address criteria for evaluating the quality, safety and efficacy of herbal medicines.  National and international policies on regulation of phytomedicines will also be discussed.


Session 7 Speakers

Joerg Grunewald
Phytopharm Consulting GmbH, Germany

International Regulatory Requirements for Medicinal Plants

Gabriel Osuide
National Agency for Food Drug Administration and Control, Nigeria

Regulation Of Herbal Medicines In Nigeria: The Role Of The National Agency For Food Drug Administration And Control

V. Srini Srinivasan
US Pharmacopoeia, USA

Challenges And Opportunities In The Development And Establishment Of Public Standards For Botanicals And Their Preparations

Robert Anton
University Louis Pasteur of Strasbourg, France

Some Aspects Of The European Regulatory Requirements Related With Phytomedicines, Nutraceuticals And Cosmetics

Iwe P. Akubue
International Center for Ethnomedicine and Drug Research, Nigeria

(to be announced)



Sourcing of traditional remedies: Case studies of African, Asian and Latin American Markets

The screening of plants, animals and microorganisms for properties of economic interest is one of the key likely activities in the life sciences industry. This session will discuss how such biodiversity prospecting activities are being carried out, the link with biotechnology and identify ways in which these activities and conservation goals can be mutually combined to achieve sustainable development.


Session 8 Speakers

Elaine Elisabetsky
Universidade Federal do Rio Grande do Sul, Brazil

Most Popular Traditional Remedies From Brazilian Amazon: An Analysis

Elijah Sokomba
West African Pharmaceutical Federation

Development Of Herbal Medicines From Traditional Remedies – Perceptive From West African Sub-Region

Joseph Okogun
National Institute for Pharmaceutical Research and Development, Nigeria

Drug Discovery Through Ethnobotany In Nigeria: Some Results

Nigel Gericke
African Natural Health, South Africa

Plants, Products and People – Southern African Perspectives

Barry Foula
Gammel Abdel University, Guinea

Experiences From Research On Plants Used In Guinean Ethnomedicine

Pei Shengji
The Chinese Academy of Sciences

The Transition Of Traditional Society And Traditional Medicine



Nutraceuticals – An Age-Long Health Practice & Healers/Practitioners Role in the Sustainable Use and Conservation of Botanical Medicines

Nutrition research is the scientific basis of the evolving nutraceutical industry. In this session, speakers from a diverse set of industries and nutraceutical venues will discuss the evolutionary trends and priorities of various stakeholders.


Session 9 Speakers

Tim Johns 
Centre for Indigenous Peoples’ Nutrition and Environment, McGill University, Canada

Traditional Additives Of East African Pastorialists As Potent Nutraceuticals

Lisa Meserole
Botanical Medicine Academy, USA

Medicinal Plants In Non Standardized Form In Anti-Aging Therapy: Reducers Of Physiological Decline And Degenerative Disease

Denis Awang
MediPlant Consulting, Canada
(to be announced)

Colin Broughton
Health Protection Branch, Health, Canada

(to be announced)

Marianne Guerin-McManus
Conservation International, USA

The use of Conservation Trust Fund for Sharing Financial Benefits in Bioprospecting Projects

Richard Cech
Horizon Herbs, USA

Balancing Conservation With Utilization

Ferdosi Begum
Development of Biotechnology and environmental Conservation Center, Bangladesh

Ex-situ Conservation of Medicinal Plants by Backyard Home Garden

A lively exhibition of Cultures and Ethnomedicine from different parts of the world


       -  Indigenous Forest and Food Products
                       - Instrumentation and Dances
                                          - Crafts and Ornaments
                                                  - Healing Practices
                                                              - Music

Venue: Holiday Inn, Silver Spring, MD
Time: Open to the conference participants and the public all day, November 3rd - 5th, 1999.
- Opening Ceremony  at 12noon on Wednesday 3rd, November, 1999-

Contact: Dr. Oma Obijiofor (301) 319-9763 / (301) 962-9201

International Office:
Bioresources Development and Conservation Programme 11303 Amherst Avenue, Suite 2 Silver Spring, Maryland 20902 U.S.A.
Phone: 301-962-6201
Fax: 301-962-6205 Email:

Administrative Offices